Ovarian cancer: NHS approves ‘first in over 20 years’ drug that offers women more time and better quality of life
A groundbreaking drug, Elahere, has been approved in the UK, offering new hope for women with advanced ovarian cancer resistant to chemotherapy.
This targeted therapy, an antibody-drug conjugate, delivers treatment directly to cancer cells, minimizing side effects.
Clinical trials show it significantly extends survival and slows disease progression, marking a major advance in treatment options.
Ovarian Cancer Drug Approved by NHS
- NHS approves first new ovarian cancer treatment for 20 years Sky News —
- Breakthrough ovarian cancer drug offers patients more time and better quality of life BBC News —
- Hope for thousands of ovarian cancer patients as new drug which slashes risk of death by a third is made available on the NHS Daily Mail —
- Life-prolonging drug for advanced ovarian cancer gets go-ahead in England The Guardian —
- 'Significant breakthrough' as new ovarian cancer treatment approved for NHS use The Standard —